People · Operator

Peter Gotcher

Named in public records as an officer, director or promoter · active 2015–2017 · Other Technology

2
Companies
3
Filings
$94.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Jaunt, Inc.Other TechnologySeries C$66.7M$2.1B2015
Halo Neuro Inc.Other TechnologySeries B$27.9M$546.3M2017
Operator network

Peter Gotcher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Rick Hess · 6 companies · 1 sharedRick HessTimothy Haley · 3 companies · 1 sharedTimothy HaleyAlex Taussig · 2 companies · 1 sharedAlex TaussigDavid Anderman · 2 companies · 1 sharedDavid AndermanArthur Van Hoff · 1 companies · 1 sharedArthur Van HoffJens Christensen · 1 companies · 1 sharedJens ChristensenKevin Mayer · 1 companies · 1 sharedKevin MayerLi Ruigang · 1 companies · 1 sharedLi RuigangAndrew Firlik · 14 companies · 1 sharedAndrew FirlikHeath Lukatch · 10 companies · 1 sharedHeath LukatchPeter Hebert · 7 companies · 1 sharedPeter HebertAmol Sarva · 6 companies · 1 sharedAmol SarvaDaniel Chao · 3 companies · 1 sharedDaniel ChaoDaniel Chao, M.D., M.S. · 1 companies · 1 sharedDaniel Chao, M.D.…Jaunt, Inc. · $66.7M raisedJaunt, Inc.Halo Neuro Inc. · $27.9M raisedHalo Neuro Inc.Peter GotcherPG
Peter Gotcher Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Peter Gotcher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Andrew Firlik114
Heath Lukatch110
Peter Hebert17
Rick Hess16
Amol Sarva16
Daniel Chao13
Timothy Haley13
David Anderman12
Alex Taussig12
Jens Christensen11
Daniel Chao, M.D., M.S.11
Kevin Mayer11
Li Ruigang11
Arthur Van Hoff11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.